INTRODUCTION
The best weapon against diabetic retinopathy is early detection, but compliance with diabetic retinal exams is low. Less than 60% of people with diabetes have recommended yearly screenings for diabetic retinopathy.1 Yet, up to 95% of diabetes-related vision loss can be prevented if caught and treated early.
Teleretinal imaging has been demonstrated to increase compliance rates for diabetic retinal exams with some clinics achieving compliance up to 90%.2 However, few studies have examined the long-term outcomes of patients receiving a teleretinal diabetic retinal exam.
STUDY OBJECTIVE
Summit Medical Group (SMG) is a large primary care organization spanning 13 different counties in eastern Tennessee with more than 300 providers in 66 offices. SMG implemented the RetinaVue care delivery model in 2015 to provide diabetic retinal exams to their patients at their annual office visit. A 2020 study by Stebbins, Kieltyka and Chaum analyzed the compliance of patients who were referred for specialist care based on their results from the diabetic retinal exam:3
1. Do patients referred for diabetic retinopathy (DR) from the RetinaVue care delivery model attend their follow-up appointments?
2. What is the accuracy of the referrals provided from the RetinaVue care delivery model?
STUDY METHODS
Since implementing the RetinaVue care delivery model in 2015, SMG has offered diabetic retinal eye exams to all their diabetic patients. SMG’s clinicians acquire the retinal images on both the right and left eye using the Welch Allyn RetinaVue 100 Imager during a patient's routine office visit. The clinician then transfers the fundus images through the Welch Allyn RetinaVue Network software to a team of board-certified ophthalmologists (RetinaVue, P.C.) who provide a diagnostic report and referral/care plan. Patients with referable DR are then recommended to follow up with an eye care specialist, including those with:
To determine how many of these patients complied with this recommendation, SMG searched their records through the RetinaVue Network database (June 2015 through October 2017). From those patients, an additional search was conducted in the electronic medical record (EMR) database to identify:
STUDY OUTCOMES: FOLLOW-UP COMPLIANCE
Based on the records from the EMR and the RetinaVue Network database, a total of 110 patients were identified with pathology for which referral was recommended. Of the 110 patients that SMG referred for follow-up care by ophthalmologists, 83 attended their appointment within one year, a 75.5% compliance rate. Previous teleretinal imaging studies examining patient follow-up rates for up to two years have recorded compliance rates ranging from 49.1% to 60%.4-7
Key takeaway: SMG experienced a 75.5% compliance rate for patients who were identified with pathology for which referral was recommended and attended follow-up appointments within one year of referral.
FOLLOW-UP TREATMENT RESULTS
The 83 patients who attended their follow-up appointment within one year were broken down into the following eye conditions based on diagnosis upon follow-up:
MISSED FOLLOW-UP
Of the 27 patients who did not attend a referral appointment within one year, 74.1% (20/27) had documented reasons for non-compliance:
CONCLUSION
This study demonstrated that primary care based teleretinal imaging may result in higher compliance rates and accurate referrals for the eye care specialist.
Results show that 75.5% of SMG patients followed the recommended care plan — typically a referral to the eye specialist — within one year. Overall follow-up compliance increased to 83.6% when including patients who followed up after one year but within two years of their initial teleretinal imaging. Based on the results from the EMR, 89.2% of those patients were diagnosed with some level of DR upon follow-up assessment by the eye care specialist.
Increasing access to the diabetic retinal exam in primary care settings effectively identifies previously undetected eye disease, ensuring timely treatment to help preserve vision.
Baxter note: an area for improvement in the U.S. healthcare system in general — is an area with potential improvement in the U.S healthcare system in general. While documentation of the diabetic eye exam in primary care settings is one of the benefits of teleretinal programs, primary care documentation of compliance with specialist referrals and treatments can still be a challenge as documented by the 25.9% of non-compliant patients with no follow-up and no documented reason for non-compliance. The primary care providers for the patients in this study contacted the specialist practices to obtain records missing from the primary care files. Better on-going communication and documentation between primary care providers and specialists will improve care planning and care delivery since primary care providers are ideally positioned to encourage compliance with follow-up appointments and treatment.
Baxter, Hillrom, RetinaVue and Welch Allyn are trademarks of Baxter International Inc. or its subsidiaries.
US-FLC147-240147 (v1.0) 10/2024